ArticleActa diabetologica2025
Glucokinase activators contribute to gastrointestinal disease risks through metabolic-immune interplay in the gut-liver axis: insights from a multi-omics study.
Yunlan Zhou et al.PubMed ↗Publisher ↗
No numbers read from the abstract.